propranolol has been researched along with Parkinson Disease in 83 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of long-acting propranolol hydrochloride (160 mg/d), primidone (250 mg at night), and clonazepam (4 mg/d) on the resting, postural, and kinetic component of tremor was investigated in ten parkinsonian patients in a double-blind crossover design." | 5.06 | Adjuvant therapy of parkinsonian tremor. ( Herbster, G; Koller, WC, 1987) |
| "Medications useful for treating tremor are discussed in this review, including those for action tremor as seen in essential tremor, the resting tremor of Parkinson's disease, orthostatic tremor, cerebellar tremor, Holmes tremor, dystonic tremor, and drug-induced tremors." | 2.82 | Medications used to treat tremors. ( Frei, K; Truong, DD, 2022) |
| "Tremor was assessed via accelerometry and surface EMG." | 2.68 | 'Atypical' tremor. ( Byth, K; Einstein, R; Henderson, JM; Jackson, DM; Morris, JG, 1995) |
| "Seven patients suffering from Parkinson's disease (PD) with severely disabling dyskinesia received low-dose propranolol as an adjunct to the currently used medical treatment." | 2.68 | Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease. ( Agid, Y; Bonnet, AM; Carpentier, AF; Vidailhet, M, 1996) |
| "In the Parkinson's disease group studied, the frequency, EMG pattern of bursts, and response to L-Dopa were similar for the two tremors (median improvement of RT by 70% and PT by 61%)." | 2.67 | Postural tremor of Parkinson's disease. ( Byth, K; Einstein, R; Henderson, JM; Jackson, D; Morris, JG; Yiannikas, C, 1994) |
| "Essential tremor is one of the most common movement disorders." | 2.61 | Essential Tremor. ( Reich, SG, 2019) |
| "Essential tremor is a common neurologic problem seen widely at all levels of patient care." | 2.47 | Essential tremor: choosing the right management plan for your patient. ( Abboud, H; Ahmed, A; Fernandez, HH, 2011) |
| "Classical rest tremors are improved by dopaminergic substances (levodopa, dopamine agonists) or anticholinergics." | 2.44 | [Tremor]. ( Deuschl, G; Raethjen, J, 2007) |
| "Resting tremor in Parkinson's disease is usually not the primary disabling feature, and in most cases, levodopa/carbidopa is satisfactory for many years." | 2.43 | Pharmacological treatment of disabling tremor. ( Charles, PD; Duffis, EI; Schadt, CR, 2005) |
| "Essential tremor is a common movement disorder in adults that interferes with the performance of functional and social activities." | 2.42 | Essential tremor: diagnosis and treatment. ( Chen, JJ; Swope, DM, 2003) |
| "Tremor-predominant Parkinson's disease is characterised by prominent tremor of one or more limbs with a relative lack of significant rigidity and bradykinesia." | 2.41 | Tremor-predominant Parkinson's disease. Approaches to treatment. ( Koller, W; Marjama-Lyons, J, 2000) |
| "This tremor is normally recordable at a stable frequency of 8-10 Hz, though this can be influenced by age, the amplitude can vary substantially." | 2.39 | [Most frequent causes for hand tremor in clinical practice]. ( Málly, J, 1995) |
| "Tremor is an involuntary oscillation of body parts that may be physiologic or pathologic." | 2.37 | Diagnosis and treatment of tremors. ( Koller, WC, 1984) |
| "Physiologic tremor is present in normal persons and is asymptomatic." | 2.36 | Physiologic and pathologic tremors. Diagnosis, mechanism, and management. ( Fahn, S; Jankovic, J, 1980) |
| "To verify the previously reported association between long-term use of β2-adrenoreceptor (β2AR) agonist and antagonist with reduced and increased risk of Parkinson disease (PD), respectively." | 1.51 | Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease. ( Blaabjerg, M; Christensen, K; Deuschl, G; Höglinger, GU; Hopfner, F; Kuhlenbäumer, G; Pottegård, A; Rösler, TW; Wod, M, 2019) |
| "Piperine has been shown to have a wide range of activity, including MAO inhibitory activity." | 1.38 | Inhibition of monoamine oxidase by derivatives of piperine, an alkaloid from the pepper plant Piper nigrum, for possible use in Parkinson's disease. ( Al-Baghdadi, OB; Geldenhuys, WJ; Prater, NI; Van der Schyf, CJ, 2012) |
| "Six patients with neuroleptic-induced akathisia were treated with the hydrophilic beta-blocker nadolol." | 1.28 | Studies on the time course and efficacy of beta-blockers in neuroleptic-induced akathisia and the akathisia of idiopathic Parkinson's disease. ( Adler, LA; Angrist, B; Rotrosen, J; Weinreb, H, 1991) |
| "Essential tremor is a common disorder whose aetiology is unknown." | 1.27 | Essential tremor. ( Findley, LJ, 1986) |
| "Essential tremor is less incapacitating than parkinsonism and less inexorably progressive." | 1.26 | Benign essential tremor: features that aid in diagnosis. ( Paulson, GW, 1982) |
| "The typical 'tremor-at-rest' of Parkinson's disease--3-7 Hz activity which alternates between antagonistic muscles--is suppressed, at least briefly, during voluntary activity, at which time typical 8--12 Hz 'physiological tremor' may be seen." | 1.26 | Physiological and pharmacological aids in the differential diagnosis of tremor. ( Shahani, BT; Young, RR, 1976) |
| "Propranolol is beneficial." | 1.26 | The shaking patient. Diagnosis and management of tremor. ( McKinney, AS, 1977) |
| "Levodopa-induced myoclonus may be related to intermittent increases of activity of serotonin in the brain and results from levodopa-induced dysregulation of serotonin activity." | 1.25 | Levodopa-induced myoclonus. ( Bergen, D; Goetz, C; Klawans, HL, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 57 (68.67) | 18.7374 |
| 1990's | 8 (9.64) | 18.2507 |
| 2000's | 7 (8.43) | 29.6817 |
| 2010's | 8 (9.64) | 24.3611 |
| 2020's | 3 (3.61) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Y | 1 |
| Liu, G | 1 |
| Chen, J | 1 |
| Reddy, PS | 1 |
| Yoon, IS | 1 |
| Zhang, M | 1 |
| Zhang, B | 1 |
| Barber, JR | 1 |
| Ng, SC | 1 |
| Al-Baghdadi, OB | 1 |
| Prater, NI | 1 |
| Van der Schyf, CJ | 1 |
| Geldenhuys, WJ | 1 |
| Saengphatrachai, W | 1 |
| Praditukrit, K | 1 |
| Owattanapanich, W | 1 |
| Pitakpatapee, Y | 1 |
| Srivanitchapoom, P | 1 |
| Frei, K | 1 |
| Truong, DD | 1 |
| Hopfner, F | 2 |
| Höglinger, GU | 2 |
| Kuhlenbäumer, G | 2 |
| Pottegård, A | 2 |
| Wod, M | 2 |
| Christensen, K | 2 |
| Tanner, CM | 1 |
| Deuschl, G | 3 |
| Mittal, S | 1 |
| Bjørnevik, K | 1 |
| Im, DS | 1 |
| Flierl, A | 1 |
| Dong, X | 1 |
| Locascio, JJ | 1 |
| Abo, KM | 1 |
| Long, E | 1 |
| Jin, M | 1 |
| Xu, B | 1 |
| Xiang, YK | 1 |
| Rochet, JC | 1 |
| Engeland, A | 1 |
| Rizzu, P | 1 |
| Heutink, P | 1 |
| Bartels, T | 1 |
| Selkoe, DJ | 1 |
| Caldarone, BJ | 1 |
| Glicksman, MA | 1 |
| Khurana, V | 1 |
| Schüle, B | 1 |
| Park, DS | 1 |
| Riise, T | 1 |
| Scherzer, CR | 1 |
| Reich, SG | 1 |
| Blaabjerg, M | 1 |
| Rösler, TW | 1 |
| Fitzgerald, PJ | 1 |
| Wick, JY | 1 |
| Zanni, GR | 1 |
| Barnum, CJ | 1 |
| Bhide, N | 1 |
| Lindenbach, D | 1 |
| Surrena, MA | 1 |
| Goldenberg, AA | 1 |
| Tignor, S | 1 |
| Klioueva, A | 1 |
| Walters, H | 1 |
| Bishop, C | 1 |
| Abboud, H | 1 |
| Ahmed, A | 1 |
| Fernandez, HH | 1 |
| Yaman, A | 1 |
| Akdeniz, M | 1 |
| Yaman, H | 1 |
| Chen, JJ | 1 |
| Swope, DM | 1 |
| Schadt, CR | 1 |
| Duffis, EI | 1 |
| Charles, PD | 1 |
| Raethjen, J | 1 |
| Strang, RR | 2 |
| Marsden, CD | 4 |
| Foley, TH | 1 |
| Owen, DA | 3 |
| McAllister, RG | 1 |
| Corbett, JL | 1 |
| Kurlan, R | 1 |
| Shoulson, I | 1 |
| Kurako, IuL | 1 |
| Volianskiĭ, VE | 1 |
| Koller, WC | 3 |
| Biary, N | 1 |
| Jankovic, J | 1 |
| Fahn, S | 1 |
| Hawkins, S | 1 |
| Prout, BJ | 1 |
| Paulson, GW | 1 |
| Sandyk, R | 1 |
| Málly, J | 1 |
| Nguyen, PB | 1 |
| Hart, LL | 1 |
| Marchand, L | 1 |
| Henderson, JM | 2 |
| Einstein, R | 2 |
| Jackson, DM | 1 |
| Byth, K | 2 |
| Morris, JG | 2 |
| Carpentier, AF | 1 |
| Bonnet, AM | 1 |
| Vidailhet, M | 1 |
| Agid, Y | 1 |
| Yiannikas, C | 1 |
| Jackson, D | 1 |
| Marjama-Lyons, J | 1 |
| Koller, W | 1 |
| Gabriel, E | 1 |
| Karobath, M | 1 |
| Lenz, G | 1 |
| Shahani, BT | 1 |
| Young, RR | 3 |
| Casacchia, M | 1 |
| Carolei, A | 1 |
| Zamponi, A | 1 |
| Agnoli, A | 1 |
| Fazio, C | 1 |
| Belmaker, RH | 1 |
| Ebstein, RP | 1 |
| Biederman, J | 1 |
| Stern, R | 1 |
| Berman, M | 1 |
| van Praag, HM | 1 |
| Schoenen, J | 2 |
| Delwaide, PJ | 2 |
| Beasley, BA | 1 |
| Ford, DH | 1 |
| McKinney, AS | 1 |
| Klawans, HL | 1 |
| Goetz, C | 1 |
| Bergen, D | 1 |
| Rivera, VM | 1 |
| Keichian, AH | 1 |
| Oliver, RE | 1 |
| Rajput, AH | 1 |
| Jamieson, H | 1 |
| Hirsh, S | 1 |
| Quraishi, A | 1 |
| Bhaskar, PA | 1 |
| Bhaskar, EA | 1 |
| Jagannathan, K | 1 |
| Arushanian, EB | 1 |
| Davis, DA | 1 |
| Landstrom, DL | 1 |
| Thong, NN | 1 |
| Adler, LA | 1 |
| Angrist, B | 1 |
| Weinreb, H | 1 |
| Rotrosen, J | 1 |
| Diener, HC | 1 |
| Cantello, R | 1 |
| Aguggia, M | 1 |
| Gilli, M | 1 |
| Delsedime, M | 1 |
| Riccio, A | 1 |
| Rainero, I | 1 |
| Mutani, R | 1 |
| Herbster, G | 1 |
| Findley, LJ | 1 |
| Kissel, P | 2 |
| Tridon, P | 2 |
| André, JM | 2 |
| Camanni, F | 1 |
| Massara, F | 1 |
| Parkes, JD | 1 |
| Rees, JE | 1 |
| Floru, L | 1 |
| Vas, CJ | 1 |
| Jacobi, H | 1 |
| Kusus, T | 1 |
| Schnelle, K | 1 |
| Lydtin, H | 1 |
| Jurna, I | 1 |
| Nell, T | 1 |
| Schreyer, I | 1 |
| Erikssen, J | 1 |
| Schmutzler, F | 1 |
| Eichhorn, A | 1 |
| Abramsky, O | 2 |
| Carmon, A | 1 |
| Lavy, S | 2 |
| von Egidy, H | 1 |
| Marks, ES | 1 |
| Whitsett, TL | 1 |
| Goldberg, LI | 1 |
| Gilligan, BS | 1 |
| Veale, JL | 1 |
| Wodak, J | 1 |
| Imura, H | 1 |
| Nakai, Y | 1 |
| Matsukura, S | 1 |
| Matsuyama, H | 1 |
| Masingue, M | 1 |
| Murray, TJ | 1 |
| Ban, T | 1 |
| Hojo, M | 1 |
| Sevitt, I | 1 |
| Schwab, RS | 1 |
| Duvoisin, RC | 1 |
| Avenarius, HJ | 1 |
| Gerstenbrand, F | 1 |
| Kruse-Larsen, C | 1 |
| Aquilonius, SM | 1 |
| Tiselius, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Measuring Cortisol Levels in Persons With Parkinson's (PD)[NCT02727270] | 131 participants (Actual) | Observational | 2016-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
21 reviews available for propranolol and Parkinson Disease
| Article | Year |
|---|---|
The association between developing Parkinson's disease and β-Adrenoceptor acting agents use: A systematic review and meta-analysis.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cohort Studies; Humans; Neurodegenerative Dis | 2021 |
Medications used to treat tremors.
Topics: Ataxia; Essential Tremor; Humans; Parkinson Disease; Propranolol; Tremor | 2022 |
β-adrenoreceptors and the risk of Parkinson's disease.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Humans; Parkinson Disease; Propranolol; Recep | 2020 |
Essential Tremor.
Topics: Adrenergic beta-Antagonists; Aged; Deep Brain Stimulation; Diagnosis, Differential; Essential Tremor | 2019 |
Essential tremor: symptoms and treatment.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anticonvulsants; Essential Tremor; Humans; Mid | 2008 |
Essential tremor: choosing the right management plan for your patient.
Topics: Adrenergic beta-Antagonists; Anticonvulsants; Botulinum Toxins; Deep Brain Stimulation; Diagnosis, D | 2011 |
How best to address these common movement disorders.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Anticonvulsants; Antiparkinson Agents; Es | 2011 |
Essential tremor: diagnosis and treatment.
Topics: Acetates; Amines; Cyclohexanecarboxylic Acids; Diagnosis, Differential; Essential Tremor; Gabapentin | 2003 |
Pharmacological treatment of disabling tremor.
Topics: Botulinum Toxins, Type A; Dystonia; Essential Tremor; Humans; Parkinson Disease; Primidone; Proprano | 2005 |
[Tremor].
Topics: Adrenergic beta-Antagonists; Anticonvulsants; Antiparkinson Agents; Botulinum Toxins; Cholinergic Ag | 2007 |
Up and down regulation: clinical significance of nervous system receptor-drug interactions.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Dyskinesia, Drug-Induced; Humans; Nervo | 1982 |
[New directions in contemporary pharmacotherapy of parkinsonism (review)].
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antiparkinson Agents; Apomorphine; Aromatic Amino | 1984 |
Diagnosis and treatment of tremors.
Topics: Cerebellar Diseases; Diagnosis, Differential; Ethanol; Humans; Parkinson Disease; Propranolol; Tremo | 1984 |
Physiologic and pathologic tremors. Diagnosis, mechanism, and management.
Topics: Alcoholic Beverages; Antiparkinson Agents; Cerebellar Diseases; Humans; Parkinson Disease; Propranol | 1980 |
Postural hypotension and its management.
Topics: Blood Volume; Cardiac Output; Clothing; Dihydroergotamine; Fludrocortisone; Humans; Hypotension, Ort | 1982 |
[Most frequent causes for hand tremor in clinical practice].
Topics: Aged; Aged, 80 and over; Aging; Female; Hand; Humans; Hypokinesia; Male; Parkinson Disease; Posture; | 1995 |
Dronabinol in tremor.
Topics: Age Factors; Dronabinol; Female; Humans; Male; Parkinson Disease; Primidone; Propranolol; Tremor | 1993 |
Tremor-predominant Parkinson's disease. Approaches to treatment.
Topics: Acetates; Amantadine; Amines; Antiparkinson Agents; Botulinum Toxins; Cholinergic Antagonists; Clona | 2000 |
Aging and the extrapyramidal system.
Topics: Aged; Aging; Basal Ganglia Diseases; Chlorpromazine; Chorea; Dopamine; Frontal Lobe; Gait; Haloperid | 1976 |
[Blocking of adrenergic beta-receptors. A new therapeutic principle].
Topics: Angina Pectoris; Aortic Valve Stenosis; Arrhythmias, Cardiac; Blood Vessels; Bronchi; Cardiovascular | 1968 |
[Antiparkinson agents. 50].
Topics: Atropine; Dihydroxyphenylalanine; Diphenhydramine; Histamine H1 Antagonists; Humans; Mephenesin; Mon | 1970 |
16 trials available for propranolol and Parkinson Disease
| Article | Year |
|---|---|
Peripheral beta-adrenergic receptors concerned with tremor.
Topics: Adult; Arteries; Blood Circulation; Bradykinin; Catecholamines; Epinephrine; Fingers; Forearm; Human | 1967 |
Effect of alcohol on tremors: comparison with propranolol.
Topics: Adult; Cerebellar Diseases; Ethanol; Humans; Male; Middle Aged; Multiple Sclerosis; Parkinson Diseas | 1984 |
'Atypical' tremor.
Topics: Benserazide; Child; Child, Preschool; Cross-Over Studies; Double-Blind Method; Drug Combinations; El | 1995 |
Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease.
Topics: Adrenergic beta-Antagonists; Adult; Antiparkinson Agents; Female; Humans; Levodopa; Male; Movement D | 1996 |
Postural tremor of Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Electromyography; Female; Humans; Levodopa; Male; Mi | 1994 |
[Indications for beta-blockers in neurology].
Topics: Alcoholism; Antiparkinson Agents; Anxiety; Clinical Trials as Topic; Drug Therapy, Combination; Huma | 1978 |
Analgesic action of methylphenidate on parkinsonian sensory symptoms. Mechanisms and pathophysiological implications.
Topics: Aged; Analgesics; Biogenic Amines; Biomechanical Phenomena; Humans; Male; Methylphenidate; Methyserg | 1988 |
Adjuvant therapy of parkinsonian tremor.
Topics: Aged; Antiparkinson Agents; Carbidopa; Clonazepam; Double-Blind Method; Drug Therapy, Combination; H | 1987 |
Letter: Levodopa-propranolol therapy in parkinsonian tremor.
Topics: Blood-Brain Barrier; Dihydroxyphenylalanine; Drug Synergism; Drug Therapy, Combination; Humans; Neur | 1974 |
Letter: Propranolol in Parkinson's disease.
Topics: Dihydroxyphenylalanine; Drug Evaluation; Drug Therapy, Combination; Humans; Parkinson Disease; Place | 1974 |
[Clinical treatment of lithium induced tremors with a beta receptor antagonist (propranolol)].
Topics: Adjustment Disorders; Adrenergic beta-Antagonists; Bipolar Disorder; Chemical Phenomena; Chemistry; | 1971 |
Propranolol in parkinsonian tremor.
Topics: Clinical Trials as Topic; Female; Humans; Male; Parkinson Disease; Propranolol; Sympatholytics | 1966 |
Effect of adrenergic beta-blockade on parkinsonian tremor.
Topics: Epinephrine; Ethanolamines; Humans; Parkinson Disease; Placebos; Propranolol; Tremor | 1965 |
Effects of levodopa on systolic preejection period, blood pressure, and heart rate during acute and chronic treatment of Parkinson's disease.
Topics: Blood Pressure; Cardiac Output; Clinical Trials as Topic; Dihydroxyphenylalanine; Dopamine; Electroc | 1972 |
Propranolol in the treatment of tremor.
Topics: Clinical Trials as Topic; Emotions; Humans; Parkinson Disease; Placebos; Propranolol; Tremor | 1972 |
[Therapy of hypokinesia-akinesia in parkinsonism with beta-receptor-blocking agents. A clinical trial].
Topics: Adult; Aged; Cryosurgery; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease; | 1969 |
46 other studies available for propranolol and Parkinson Disease
| Article | Year |
|---|---|
Pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione derivatives: their cytoprotection effect from rotenone toxicity and preliminary DMPK properties.
Topics: Animals; Cytoprotection; Insecticides; Male; Microsomes, Liver; Parkinson Disease; Rats; Rotenone; S | 2009 |
Inhibition of monoamine oxidase by derivatives of piperine, an alkaloid from the pepper plant Piper nigrum, for possible use in Parkinson's disease.
Topics: Alkaloids; Animals; Benzodioxoles; Binding Sites; Blood-Brain Barrier; Cattle; Humans; Hydrogen Bond | 2012 |
β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease.
Topics: Acetylation; Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Antagonists; Albuterol; alpha-Synu | 2017 |
Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adrenergic beta-Antag | 2019 |
Is elevated norepinephrine an etiological factor in some cases of Parkinson's disease?
Topics: Animals; Antidepressive Agents; Bipolar Disorder; Disease Progression; Humans; Mice; Models, Theoret | 2014 |
Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adrenergic Neurons; Animals; Behavior, An | 2012 |
My husband has been diagnosed with essential tremor, or ET. What is this, and how is it different from Parkinson's disease? What is the treatment?
Topics: Essential Tremor; Humans; Parkinson Disease; Propranolol | 2008 |
The symptom of restless legs.
Topics: Adult; Aged; Anemia, Hypochromic; Chlordiazepoxide; Diazepam; Female; Humans; Iron; Leg; Male; Middl | 1967 |
Mechanisms underlying emotional variation in parkinsonian tremor.
Topics: Drug Antagonism; Epinephrine; Humans; Hypoglycemia; Insulin; Movement; Parkinson Disease; Problem So | 1967 |
Beta adrenergic blockers in tremor.
Topics: Adrenergic beta-Antagonists; Anxiety; Humans; Oxprenolol; Parkinson Disease; Propranolol; Tremor | 1981 |
Benign essential tremor: features that aid in diagnosis.
Topics: Adolescent; Adult; Aged; Alcohol Drinking; Child; Diagnosis, Differential; Female; Head; Humans; Mal | 1982 |
The effect of propranolol on parkinsonian tremor induced by peripheral trauma.
Topics: Female; Humans; Parkinson Disease; Propranolol; Radius Fractures | 1982 |
[Treatment of essential tremor].
Topics: Anti-Anxiety Agents; Anti-Dyskinesia Agents; Botulinum Toxins; Humans; Hypnotics and Sedatives; Meth | 1995 |
[The extrapyramidal symptoms in the combination of lithium long-term lithium therapy with nortriptyline. A case report on the formation of a pathogenesis hypothesis].
Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Chlorprothixene; Clopenthixol; Dibenzazepines; Drug | 1976 |
Physiological and pharmacological aids in the differential diagnosis of tremor.
Topics: Ataxia; Diagnosis, Differential; Ethanol; Humans; Isoproterenol; Levodopa; Methods; Parkinson Diseas | 1976 |
[Therapy of Parkinson's disease. Practical criteria of treatment].
Topics: Amantadine; Antiparkinson Agents; Benserazide; Carbidopa; Cyproheptadine; Drug Therapy, Combination; | 1976 |
The effect of L-dopa and propranolol on human CSF cyclic nucleotides.
Topics: Adult; Aged; Cyclic AMP; Cyclic GMP; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; | 1978 |
The shaking patient. Diagnosis and management of tremor.
Topics: Amantadine; Carbidopa; Cerebellar Diseases; Humans; Levodopa; Parkinson Disease; Propranolol; Tremor | 1977 |
[Neurologic indication for propranolol: essential tremor].
Topics: Adolescent; Adult; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Parkinson Disease; Pr | 1976 |
Levodopa-induced myoclonus.
Topics: 5-Hydroxytryptophan; Aged; Amantadine; Amphetamine; Animals; Benztropine; Dopamine Antagonists; Dose | 1975 |
Persistent parkinsonism following neuroleptanalgesia.
Topics: Adolescent; Anesthesia, Inhalation; Anesthesia, Intravenous; Droperidol; Female; Fentanyl; Humans; L | 1975 |
Relative efficacy of alcohol and propranolol in action tremor.
Topics: Adult; Ataxia Telangiectasia; Cerebellar Diseases; Drug Evaluation; Ethanol; Female; Humans; Male; P | 1975 |
Augmenting procedures during L-dopa therapy for Parkinsonism.
Topics: Antacids; Dextroamphetamine; Drug Synergism; Female; Humans; Imipramine; Levodopa; Male; Middle Aged | 1975 |
[The phenomenon of experimental motor retardation as one of the manifestations of the Parkinsonian syndrome].
Topics: Amphetamine; Animals; Catecholamines; Cats; Caudate Nucleus; Chlorpromazine; Dihydroergotoxine; Dise | 1975 |
Essential tremor: a common and treatable disorder.
Topics: Diagnosis, Differential; Ethanol; Humans; Parkinson Disease; Propranolol; Tremor | 1976 |
Studies on the time course and efficacy of beta-blockers in neuroleptic-induced akathisia and the akathisia of idiopathic Parkinson's disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Female; Hum | 1991 |
[Tremor. Possibilities and limits of drug therapy].
Topics: Humans; Parasympatholytics; Parkinson Disease; Primidone; Propranolol; Tremor | 1990 |
Essential tremor.
Topics: Diagnosis, Differential; Humans; Parkinson Disease; Phenobarbital; Phenylethylmalonamide; Primidone; | 1986 |
Letter: Enhancement of levodopa-induced growth-hormone stimulation by propranolol.
Topics: Dihydroxyphenylalanine; Drug Synergism; Drug Therapy, Combination; Growth Hormone; Humans; Parkinson | 1974 |
[Inhibition of tremor by active beta-adrenolytic substances].
Topics: Animals; Depression, Chemical; Isoproterenol; Mice; Parkinson Disease; Propranolol; Sensory Receptor | 1967 |
Motor disturbance induced by tremorine and oxotremorine.
Topics: Acetylcholine; Amines; Animals; Atropine; Biperiden; Brain; Bridged-Ring Compounds; Chlorpromazine; | 1970 |
[Beta-adrenergic blocking therapy in thyrotoxicosis].
Topics: Adrenergic beta-Antagonists; Aged; Female; Humans; Hyperthyroidism; Male; Middle Aged; Parkinson Dis | 1970 |
Combined treatment of Parkinsonian tremor with propranolol and levodopa.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; | 1971 |
Treatment of parkinsonism.
Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parkinson Disease; Phenothiazines; Propranolol | 1972 |
[What is assured in treatment with beta receptor blockaders?].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Cresols; Heart Diseases; Huma | 1972 |
Parkinsonism and hyperthyroidism.
Topics: Diazepam; Dihydroxyphenylalanine; Drug Therapy, Combination; Female; Humans; Hyperthyroidism; Male; | 1974 |
Effect of intravenous infusion of L-DOPA on plasma growth hormone levels in man.
Topics: Adult; Aged; Anorexia Nervosa; Blood Glucose; Central Nervous System Diseases; Dihydroxyphenylalanin | 1973 |
[L-Dopa-Propranolol association and parkinsonian trembling].
Topics: Dihydroxyphenylalanine; Drug Synergism; Humans; Parkinson Disease; Propranolol | 1972 |
Treatment of essential tremor with propranolol.
Topics: Humans; Parkinson Disease; Propranolol; Tremor | 1972 |
A comparative study of the effects of anti-parkinson drugs on the oxotremorine-induced EEG and muscular activities.
Topics: Animals; Diphenhydramine; Drug Antagonism; Electroencephalography; Male; Muscle Tonus; Muscles; Orph | 1971 |
The effect of adrenergic beta-receptor blocking drugs on tremor.
Topics: Aged; Dopamine; Female; Humans; Male; Parkinson Disease; Propranolol; Sensory Receptor Cells; Sympat | 1971 |
Non-resting tremor in Parkinson's disease.
Topics: Aged; Amantadine; Dihydroxyphenylalanine; Humans; Male; Parkinson Disease; Propranolol; Tremor | 1971 |
Hypotension caused by L-dopa.
Topics: Dihydroxyphenylalanine; Female; Humans; Hypotension; Middle Aged; Parkinson Disease; Propranolol | 1970 |
[Kr 339, a new tremor-inhibiting preparation for the therapy of Parkinson's syndrome].
Topics: Adult; Aged; Chemical Phenomena; Chemistry; Drug Synergism; Female; Humans; Male; Middle Aged; Muscl | 1968 |
Measurement of rigidity and tremor in Parkinson's disease.
Topics: Elasticity; Humans; Joint Diseases; Joints; Movement; Orphenadrine; Oscillometry; Parasympatholytics | 1969 |
Clinical trial with a beta-receptor antagonist (propranolol) in parkinsonism.
Topics: Adult; Female; Humans; Male; Parkinson Disease; Prognosis; Propranolol; Statistics as Topic; Sympath | 1965 |